Goldman Sachs
TNGX icon

Goldman Sachs’s Tango Therapeutics TNGX Stock Holding History

Goldman Sachs’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$106M Buy
5,076,392
+133,978
+3% +$1.86M 0.01% 987
2025
Q4 		$43.8M Buy
4,942,414
+3,432,939
+227% +$29.6M 0.01% 1617
2025
Q3 		$12.7M Buy
1,509,475
+1,401,296
+1,295% +$9.48M ﹤0.01% 2735
2025
Q2 		$554K Sell
108,179
-64,254
-37% -$159K ﹤0.01% 5095
2025
Q1 		$236K Sell
172,433
-314,455
-65% -$772K ﹤0.01% 5568
2024
Q4 		$1.5M Sell
486,888
-56,609
-10% -$263K ﹤0.01% 4528
2024
Q3 		$4.18M Sell
543,497
-71,421
-12% -$682K ﹤0.01% 3498
2024
Q2 		$5.28M Buy
614,918
+1,216
+0.2% +$9.4K ﹤0.01% 3101
2024
Q1 		$4.87M Buy
613,702
+164,487
+37% +$1.76M ﹤0.01% 3114
2023
Q4 		$4.45M Buy
449,215
+334,355
+291% +$2.9M ﹤0.01% 3261
2023
Q3 		$1.29M Buy
114,860
+24,293
+27% +$148K ﹤0.01% 4087
2023
Q2 		$301K Buy
90,567
+9,408
+12% +$33.8K ﹤0.01% 5003
2023
Q1 		$321K Buy
81,159
+11,125
+16% +$64.6K ﹤0.01% 5071
2022
Q4 		$508K Sell
70,034
-204,552
-74% -$1.44M ﹤0.01% 4857
2022
Q3 		$994K Buy
274,586
+194,191
+242% +$829K ﹤0.01% 4507
2022
Q2 		$364K Sell
80,395
-21,391
-21% -$130K ﹤0.01% 5301
2022
Q1 		$772K Buy
101,786
+19,180
+23% +$166K ﹤0.01% 5030
2021
Q4 		$904K Buy
+82,606
New +$993K ﹤0.01% 4932

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Goldman Sachs's TNGX Position: Q1 2026 in Review

Goldman Sachs increased its Tango Therapeutics (TNGX) stake by 2.7% in Q1 2026, buying an estimated $1.86M and bringing the position to 5,076,392 shares worth $106M. The position accounts for 0.01% of the portfolio, ranked #987.

Goldman Sachs first reported a position in TNGX in Q4 2021 and has held it in 18 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Goldman Sachs held 5,076,392 shares of Tango Therapeutics worth $106M as of Q1 2026.
  • Goldman Sachs bought 133,978 Tango Therapeutics shares in Q1 2026, an estimated $1.86M.
  • Tango Therapeutics made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #987 holding.
  • Goldman Sachs first reported a position in Tango Therapeutics in Q4 2021 and has held it in 18 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.